Yuichiro Iida

Early mobilization trajectories during Impella 5.5 support and associated outcomes in patients with cardiogenic shock: A physiotherapy session-level analysis.

Journal: Heart & lung : the journal of critical care

Published: April 14, 2026

Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation.

Journal: Circulation reports

Published: November 07, 2025

Cardiac characteristics of Fabry disease from baseline enrolment data in a nationwide prospective Japanese registry.

Journal: International journal of cardiology

Published: September 30, 2025

Hemodynamic Ramp Test in Cardiogenic Shock Supported by Microaxial Flow Pump: Protocol Description, Feasibility, and Hemodynamic Response.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: September 22, 2025

Prognostic Impact of Sustained Reduction of N-Terminal Pro-B-Type Natriuretic Peptide After Initiating Sacubitril/Valsartan　- Insights From the REVIEW-HF Registry.

Journal: Circulation reports

Published: February 12, 2025

Heart-rate reduction during microaxial flow pump support and short-term outcomes in patients with cardiogenic shock.

Journal: Heart and vessels

Published: October 30, 2024

Device-related adverse events and flow capacity of percutaneous ventricular assist devices.

Journal: European heart journal. Acute cardiovascular care

Published: September 24, 2024

Association Between Amount of Physical Activity and Clinical Outcomes After Treatment for Cardiovascular Disease in Cancer Survivors.

Journal: Circulation reports

Published: September 09, 2024

Characteristics and incidence of cardiac events across spectrum of age in cardiac sarcoidosis.

Journal: International journal of cardiology. Heart & vasculature

Published: October 29, 2023

Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure.

Journal: Medicina (Kaunas, Lithuania)

Published: October 29, 2023

Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.

Journal: ESC heart failure

Published: August 14, 2023

The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension.

Journal: Heart and vessels

Published: February 02, 2023

Early mobilization trajectories during Impella 5.5 support and associated outcomes in patients with cardiogenic shock: A physiotherapy session-level analysis.

Early mobilization trajectories during Impella 5.5 support and associated outcomes in patients with cardiogenic shock: A physiotherapy session-level analysis.

Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation.

Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation.

Cardiac characteristics of Fabry disease from baseline enrolment data in a nationwide prospective Japanese registry.

Cardiac characteristics of Fabry disease from baseline enrolment data in a nationwide prospective Japanese registry.

Hemodynamic Ramp Test in Cardiogenic Shock Supported by Microaxial Flow Pump: Protocol Description, Feasibility, and Hemodynamic Response.

Hemodynamic Ramp Test in Cardiogenic Shock Supported by Microaxial Flow Pump: Protocol Description, Feasibility, and Hemodynamic Response.

Prognostic Impact of Sustained Reduction of N-Terminal Pro-B-Type Natriuretic Peptide After Initiating Sacubitril/Valsartan - Insights From the REVIEW-HF Registry.

Prognostic Impact of Sustained Reduction of N-Terminal Pro-B-Type Natriuretic Peptide After Initiating Sacubitril/Valsartan - Insights From the REVIEW-HF Registry.

Heart-rate reduction during microaxial flow pump support and short-term outcomes in patients with cardiogenic shock.

Heart-rate reduction during microaxial flow pump support and short-term outcomes in patients with cardiogenic shock.

Device-related adverse events and flow capacity of percutaneous ventricular assist devices.

Device-related adverse events and flow capacity of percutaneous ventricular assist devices.

Association Between Amount of Physical Activity and Clinical Outcomes After Treatment for Cardiovascular Disease in Cancer Survivors.

Association Between Amount of Physical Activity and Clinical Outcomes After Treatment for Cardiovascular Disease in Cancer Survivors.

Characteristics and incidence of cardiac events across spectrum of age in cardiac sarcoidosis.

Characteristics and incidence of cardiac events across spectrum of age in cardiac sarcoidosis.

Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure.

Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure.

Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.

Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.

The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension.

The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension.

Prognostic Impact of Sustained Reduction of N-Terminal Pro-B-Type Natriuretic Peptide After Initiating Sacubitril/Valsartan　- Insights From the REVIEW-HF Registry.

Prognostic Impact of Sustained Reduction of N-Terminal Pro-B-Type Natriuretic Peptide After Initiating Sacubitril/Valsartan　- Insights From the REVIEW-HF Registry.